Preliminary Scientific Schedule for NPC Symposium 2015 Day1: 4-Jun-15 Etiology of NPC 08.00 - 09.00 09.00 - 09.30 Registration Opening Professor I. Bing Tan, MD, PhD (Netherlands Cancer Institute/AVL Hospital Amsterdam, NL-Universitas Gadjah Mada Yogyakarta Indonesia) 09.30 - 10.00 Keynote Address 10.00 - 10.30 Coffee Break 10.30 - 12.00 PLENARY 1 : Epidemiology (World distribution, Molecular epidemiology, and Risk factors) 10.30 - 10.50 World NPC Incidence and Risk Factors Ellen Chang, Sc.D (Stanford Cancer Institute, LA, CA,USA) 10.50 - 11.10 Familial NPC and the Use of Biomarkers Professor Chien-Jen Chen (Genomics Research Center, Academia Sinica; and Graduate Institute of Epidemiology and Preventive Medicine, National Taiwan University, Taipei, Taiwan) 11.10 - 11.20 Hospital-Based Incidence of NPC in Indonesia Marlinda Adham, MD, PhD (Universitas Indonesia, Rumah Sakit Cipto Mangunkusumo, Jakarta, Indonesia) 11.20 - 12.00 12.00 - 13.00 13.00 - 14.50 Free Papers (4) Lunch PLENARY 2: Genetic/Epigenetic Genetic Susceptibility Risk Factors for Sporadic and Familial NPC: Recent Findings Exome Sequencing and GWAS Studies on Sporadic NPC Results of GWAS and Exome Sequencing of Familia NPC 13.00 - 13.20 13.20 - 13.40 13.40 - 14.00 14.00 - 14.20 Epigenetics on NPC 14.20 - 14.50 14.50 - 15.05 15.05 - 18.00 Free Papers (3) Coffee Break PLENARY 3: EBV-Host Relationship 15.05 - 15.25 Role of Exosome in NPC 15.25 - 15.45 EBV (EBNA1) 15.45 - 16.05 Studies on EBV and Host Relationship 16.05 - 16.35 16.35 - 18.00 Free Papers (3) Poster Reception (High Tea Reception) Allan Hildesheim, PhD (DCEG, NCI, USA) Professor Jinxin Bei (Sun Yat-sen University Cancer Center, Guangzhou, China) James McKay, PhD (IARC, Lyon, France) Prof. Qian Tao (School of Biomedical Sciences, The Chinese University of Hong Kong, China) Pierre Busson, PhD (Institut de Cancérologie Gustave Roussy, Villejuif, Cedex, France) Lori Frappier, PhD (Dept of Molecular Genetics, University of Toronto, Canada) Professor Kwok-Wai Lo (University of Hong Kong, Hong Kong) Day 2: 5-Jun-15 Screening, Diagnosis and Treatment of NPC Time Program 08.00 - 10.00 PLENARY 4: NPC Screening and Awareness 08.00 - 08.20 NPC Screening Implementation in China 08.20 - 08.40 EBV Array Platform to Screen for EBV Antibodies Associated with NPC and Other EBV-Associated Disorders 08.40 - 09.00 NPC awareness 09.00 - 09.30 09.30 - 10.00 10.00 - 13.35 Free paper (3 Paper) Coffee Break PLENARY 5: Clinical Diagnosis NPC 10.00 - 10.20 Advance Imaging on NPC 10.20 - 10.40 The Advanced Role of Ultrasound in Detecting Early Oropharyngeal Cancer Lesion 10.40 - 11.30 11.30 - 13.15 13.15 13.15 - 13.35 13.35 - 14.05 14.05 - 14.25 14.25 - 15.45 14.25 - 14.45 14.45-15.05 Panel Discussion: Challenges of NPC Diagnosis in Developing Countries Speaker Su-Mei Cao, MD, PhD (Sun Yat-sen University Cancer Center, China) Professor Denise Doolan (QIMR Berghofer Medical Research Institute, The University of Queensland, Australia) Sagung Rai Indrasari, MD, MSc (Universitas Gadjah Mada/Dr. Sardjito Hospital Yogyakarta,Indonesia) Professor Ann D. King, MB BCh, MRCP, FRCR, FHKCR, FHKAM (The Chinese University of Hong Kong, China) Carole Fahkry, MD (Greater Baltimore Medical Center and The John Hopkins Hospital, USA) a. Alan Khoo Soo Beng, MD (Institute for Medical Research, Ministry of Health, Malaysia) b. Marlinda Adham, MD, PhD (Universitas Indonesia/Rumah Sakit Cipto Mangunkusumo, Jakarta,Indonesia) c. Sagung Rai Indrasari, MD, MSc (Universitas Gadjah Mada/Dr. Sardjito Hospital Yogyakarta,Indonesia) Lunch and Friday Praying PLENARY 6: Therapy: State of the Art on Primary Treatment of NPC Current Advances and Future Direction in NPC Professor Brian O'Sullivan, MB Bch BAO, FRCPC Management (University of Toronto, Toronto, Canada) Prof. Dr. med. Rolf Mertens (Universitätsklinikum Management for Juvenile NPC Aachen Klinik f. Kinder- und Jugendmedizin, Germany) Free Papers (3) PLENARY 7: Treatment Failure in NPC Chen Ming Yuan, PhD ( Affiliated Hospital of Zunyi Management of Treatment Failure in NPC Medical College, Guangzhou, China) Prof. Anne Lee (Department of Clinical Oncology, Global Pattern and Correlation of Outcome with Pamela Youde Nethersole Eastern Hospital, Access to Radiotherapy for NPC Hongkong) 15.05- 16.00 East-West Discussion on NPC Management 16.00 - 16.15 16.15 - 18.00 18.00 - 21.00 Afternoon Coffee Break Cultural Night a. Johan Kurnianda, MD (Universitas Gadjah Mada/Dr. Sardjito Hospital Yogyakarta,Indonesia) b. Prof. Dr. dr. Soehartati G., Sp.Rad(K), Onk.Rad (Universitas Indonesia/Rumah Sakit Cipto Mangunkusumo, Jakarta,Indonesia) c. Prof. I. Bing Tan MD, PhD. (Netherlands Cancer Institute-Universitas Gadjah Mada Yogyakarta, Indonesia) d. Professor Brian O’Sullivan, MB Bch BAO, FRCPC (University of Toronto, Toronto, Canada) Day 3: 6-Jun-15 Novel Approaches for NPC Diagnosis and Treatment Time Program 08.30 - 10.00 PLENARY 8: Novel Biomarker 08.30 - 08.50 EBV-based diagnosis and prognostic indicator 08.50 - 09.10 Prognostic/predictive marker Speaker Professor Maria Li Lung (Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong) Professor Mu-Sheng Zeng, MD, PhD (Cancer Institute, Sun Yat-sen University, China) 09.10 - 10.00 Free papers (5) 10.00 - 10.30 Coffee break 10.30 - 10.35 Announcement of NPC Gordon Research Conference 2016 Professor Maria Li Lung (Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong) 10.35 - 15.05 PLENARY 9: Immunology and Immunotheraphy 10.35 - 10.55 Role of HLA and KIR in NPC 10.55 - 11.15 The Role of Potentially Neutralizing Antibodies Against EBV in NPC 11.55 - 12.35 12.35 - 13.30 13.30 - 15.00 15.00 - 15.30 Anna E. Coghill, MD (National Cancer Institute, Rockville, USA) Professor Rajiv Khanna (QIMR Berghofer Medical Research Institute, University of Queensland, Australia) Results on Immunotheraphy in Clinical Toh Han Chong, MD (National Cancer Centre, Trials Singapore) Free Papers (4) Lunch Break Satellites for Free Papers (2-4 satellites) Nutrition Palliative Care Awareness Herbals Others Closing and Announcement for Next Meeting 11.15 - 11.35 Polytope Vaccine for NPC 11.35 - 11.55 Xiaojiang Gao, PhD (Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research National Cancer Institute, The Netherlands)
© Copyright 2024